Published on in Vol 8, No 11 (2022): November
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/40386, first published
.

Journals
- Yang S, Liu K, Li Y, Li G, Li J, Lin Y, Wu S. Utilization and outcomes of the 21-gene recurrence score in de novo metastatic breast cancer. Expert Review of Molecular Diagnostics 2024;24(1-2):99 View
- Tang W, Mo S, Xie Y, Wei T, Chen G, Teng Y, Jia K. Predicting Overall Survival in Patients with Male Breast Cancer: Nomogram Development and External Validation Study. JMIR Cancer 2025;11:e54625 View